By Editorial Staff
October 13, 2025
The moment a physician utters the words "Stage 4 breast cancer," the world does not merely shift; it fractures. For Miriam Sabo, that moment arrived at age 42, an age typically associated with the mid-career climb and the peak of parenting responsibilities. However, Sabo was thrust into a demographic that receives far less cultural visibility: those diagnosed with de novo metastatic breast cancer (MBC).
Accounting for approximately 6% of all breast cancer diagnoses, de novo MBC means the disease has already spread to distant organs—in Sabo’s case, the liver—at the time of the initial diagnosis. Unlike early-stage breast cancer, which is often framed through the lens of a "battle to be won," metastatic disease is characterized by a different reality: it is chronic, non-curable, and requires lifelong treatment.
This article explores the landscape of living with Stage 4 cancer, the vital role of support systems like Sharsheret, and the philosophical shift required to thrive when the traditional "survivor" narrative no longer applies.
The Chronology of a New Normal
The Initial Shock
When Sabo was diagnosed, she was faced with a medical reality that defied the ubiquitous "pink ribbon" culture of eradication. "Little can prepare you when you’re told ‘You have cancer,’" she recalls. "But nothing prepares you for being told ‘You have Stage 4 breast cancer.’"
For many patients, the immediate impulse is to search for a cure. However, for those with MBC, the medical objective shifts from curative intent to disease management and quality of life. Sabo made a conscious decision early on to reject the term "terminal." Instead, she adopted the term "non-curative," a linguistic shift that acknowledges the lifelong nature of her treatment plan without stripping her of agency.
The Turning Point: Finding a "Cancer Team"
Recognizing that the emotional toll of such a diagnosis requires more than clinical intervention, Sabo turned to Sharsheret, an organization providing specialized support for Jewish women facing breast and ovarian cancer. Years prior, she had interacted with the organization regarding BRCA testing—a test for which she ultimately tested negative—but her needs had evolved.
Sabo describes her experience with Sharsheret not as a passive patient, but as a collaborative participant in her own care. She was paired with a social worker who served as a critical "sounding board" for the psychological volatility of the early weeks. This connection eventually led her to the "Embrace" program, where she transitioned from a recipient of support to a peer mentor, helping other women navigate the same, often lonely, path.
Six Years of "Day-in and Day-out"
Today, six and a half years after her diagnosis, Sabo stands as a testament to the fact that statistics are not destiny. She has reached milestones that, at the time of diagnosis, seemed like distant dreams: watching her four children grow, attending their graduations, and witnessing two of them marry.
"I was told when I was diagnosed that I’m not milk; there’s no expiration date stamped on me," Sabo says. This mantra has become the bedrock of her existence. She emphasizes that while the "big moments" are beautiful, the true victory is found in the "day-in and day-out" moments of family life.
Supporting Data: The Landscape of Metastatic Breast Cancer
The "6% Statistic" and Diagnostic Challenges
According to the American Cancer Society and various oncological research databases, de novo metastatic breast cancer represents a specific clinical challenge. While modern medicine has significantly extended life expectancy for MBC patients, the five-year survival rate remains significantly lower than that of early-stage breast cancer.
However, medical experts caution against "Googling the statistics." Individual outcomes are increasingly driven by advancements in targeted therapies, immunotherapy, and hormone-blocking treatments. As Sabo notes, "The statistics should never be Googled." Research indicates that the heterogeneity of breast cancer means that no two patients respond identically to treatment, making individual advocacy and specialized care essential.
The Role of Psycho-Oncology
Studies published in the Journal of Clinical Oncology consistently highlight that patients with metastatic disease experience higher levels of "scanxiety"—the anxiety surrounding periodic imaging tests—and depression. Support systems like Sharsheret fill a critical gap that standard oncology departments often lack: the integration of spiritual, peer-based, and psychological support.
Peer mentorship programs, such as the one Sabo participates in, have been shown to improve patient compliance and reduce feelings of social isolation. By talking to those who have navigated the same treatment-induced side effects, patients can better manage the physical realities of living with a chronic illness.
Official Responses and Clinical Perspectives
Medical professionals who specialize in MBC treatment emphasize the shift in the "patient narrative." Dr. Elena Rossi, an oncologist specializing in metastatic disease (not involved in this case), notes: "The goal of care for metastatic patients is to maximize the time spent living well. We treat the disease like a chronic condition, such as diabetes or heart disease. The psychological component is just as important as the chemotherapy or hormonal therapy."
Sharsheret’s leadership, including Bonnie, who heads the Embrace program, emphasizes that the patient’s voice is the most valuable tool in the clinical suite. By empowering patients to become peer supporters, the organization creates a feedback loop of resilience that benefits the entire oncology community.
Implications: Changing the Cultural Narrative
Beyond the "Fighter" Archetype
The traditional cancer narrative is built on the metaphor of battle. The patient is a "warrior," and the goal is to "beat" the cancer. For the MBC patient, this narrative can be harmful. If the cancer never leaves, does the patient lose the "fight"?
Sabo’s story suggests a different path: the path of endurance and integration. By moving away from the language of war, patients can focus on the reality of their existence: they are not dying; they are living with a disease. This shift allows for the pursuit of joy and normalcy, rather than living in a state of perpetual combat.
Faith and Resilience
For many, the intersection of medical science and personal faith serves as a stabilizing force. Sabo attributes much of her ability to navigate the unpredictability of her health to her faith, stating that she holds onto the belief that "G-d’s plans are always for good, even in the hardest of moments."
This integration of faith and clinical treatment is becoming a recognized aspect of holistic oncology. Providing patients with the space to explore their existential and spiritual needs alongside their physical treatments leads to higher reported levels of life satisfaction, regardless of the stage of the disease.
The Future of MBC Care
As we move toward 2030, the outlook for MBC is shifting due to the development of Antibody-Drug Conjugates (ADCs) and other breakthrough therapies. The goal is to turn Stage 4 breast cancer into a condition that can be managed for decades.
However, as Sabo’s testimony underscores, medical advancement is only one half of the equation. The other half is the human support network. Whether through organizations like Sharsheret or through individual peer mentorship, the ability to connect with someone who understands the weight of a "forever" treatment plan is the most effective medicine for the human spirit.
Conclusion
Miriam Sabo’s story is not one of a "cure" in the traditional sense, but it is a triumph nonetheless. By rejecting the arbitrary limits placed on her by statistics and choosing to focus on the tangible, everyday beauty of life, she has rewritten the script for what it means to be a metastatic breast cancer patient.
Her life serves as a powerful reminder that while we cannot always control the biological realities of our bodies, we retain the authority to define our narratives. As she continues to live, love, and mentor others, she proves that the expiration date is not a fact—it is a perspective. For those currently sitting in a doctor’s office, reeling from a new diagnosis, her journey offers a vital piece of advice: find your team, ignore the statistics, and focus on the present, one day at a time.
About the Author
